nephrotic syndrome
Jump to navigation
Jump to search
Introduction
Defined as > 3.5 grams of protein in 24 hour urine, hypo- albuminemia, hyperlipidemia, & edema.
Etiology
- causes of glomerular proteinuria
- diabetic nephropathy (most common cause)#
- minimal change disease (children, adults)
- membranous nephropathy (elderly, white)*
- focal segmental glomerulosclerosis (African Americans)%
- renal amyloidosis -> AA-amyloidosis -> rheumatoid arthritis
- post-infectious glomerulonephritis (GN)
- IgA nephropathy
- membranoproliferative glomerulonephropathy
- systemic lupus erythematosus (SLE)
- malignancy
- multiple myeloma, lymphoma, other
- hepatitis B, hepatitis C
- HIV
- syphilis
- endocarditis
- Wegener's granulomatosis
- pharmacologic causes:
- captopril
- gold salts
- penicillamine
- probenecid
- NSAIDs
- interferon-alpha
- pamidronate
- drugs of abuse
- also see causes of nephrotic syndrome
* most common cause of idiopathic nephrotic syndrome in elderly & in white Americans[6][7]
% most common cause in African Americans[6]
# nephrotic syndrome is a late manifestation[7]
- nephrotic range proteinuria in a diabetic without microvascular disease (retinopathy) or macrovascular disease (cardiovascular disease) is not due to diabetes mellitus; obtain kidney biopsy[6]
Pathology
- loss of glomerular basement membrane barriers to protein passage
- increased permeability of the glomerular capillary basement membrane
- minimal change disease - loss of glycosaminoglycans
- membranous glomerulonephritis - loss of porous structure
- Na+ retention
- intrascular volume depletion stimulates renin-angiotensin-aldosterone axis
- increased distal tubular resorbtion of Na+
- impaired response to atrial natriuretic factor (ANF)
- edema
- nephrotic syndrome produces a hypercoagulable state associated with:
- decrease in plasma antithrombin 3 (loss of antithrombin 3 in urine)
- decrease in plasma factor IX & plasma factor XI
- decrease in plasma plasminogen
- increase in plasma fibrinogen (increased synthesis)
- increase in plasma protein C, plasma protein S
- increase in plasma alpha-2 antiplasmin
- increase in plasma factor V, plasma factor VII, plasma factor VIII, plasma factor X
- increased platelet reactivity
- thrombocytosis
- increased plasma factor IV & plasma thromboglobulin
- altered endothelial function
- venous thrombosis more common than arterial thrombosis
- susceptibility to infection
- loss of complement factor B
- loss of immunoglobulins
- hyperlipidemia
- impaired catabolism of apo-B containing lipoproteins
- alpha-1 acid glycoprotein may play role
- atherosclerosis
- loss of high-density lipoprotein
- loss of heparan sulfate
- loss of alpha-1 acid glycoprotein
- increased synthesis of apolipoprotein B & LDL
- anemia
- loss of erythropoietin
- loss of transferrin
- osteomalacia
- loss of vitamin D-binding protein
- hypothyroidism
- loss of thyroxine
- loss of thyroid hormone-binding proteins
- unknown effects
- increase in plasma alpha2-globulins & beta-globulins
- increase in plasma IgM
Clinical manifestations
- edema/anasarca
- increased serum cholesterol (usually)
- venous thromboembolism common
- hypertension may be present
- signs & symptoms of systemic lupus erythematosus
- signs & symptoms of diabetes mellitus
- hepatosplenomegaly associated with:
- gross hematuria may be present
Laboratory
- urinalysis
- microscopy:
- evidence of glomerular disease: RBC, RBC casts
- glucosuria with diabetes
- proteinuria: albuminuria (dipstick detects albumin)
- lipiduria: maltese cross fat droplets seen with polarized microscopy
- microscopy:
- urine protein > 350 mg/dL (3500 mg/L)
- urine protein/creatinine > 3.5 (g/g) (3500 mg/g)
- 24 hour urine protein > 3.5 grams (3500 mg)
- urine protein electrophoresis
- urine immunofixation electrophoresis
- serum chemistries
- HIV testing: HIV is associated with focal segmental glomerulosceloris
- urine toxicology: IV drug abuse is associated with amyloidosis
- serologies
- antinuclear antibody (ANA)
- anti glomerular basement membrane (anti-GBM)
- complement C3 & complement C4: diminished in:
- lupus nephritis
- membranoproliferative GN
- post-streptococcal GN
- postinfectious GN secondary to endocarditis
- cryoglobulins
- anti neutrophil cytoplasmic antibody (ANCA)
- elevated in Wegener's granulomatosis
- streptozyme & antistreptolysin O (ASO)
- hepatitis serologies
- hepatitis B surface antigen (HBsAg)
- hepatitics C antibody
- serum transaminases & hepatitis profile
- hepatitis may be associated with glomerular proteinuria
- lipid panel:
- hyperlipidemia
- increased total cholesterol, LDL cholesterol & Lp<a>
- thyroid function testing
- free thyroxine may be low (lost in urine)
- serum TSH may be elvated (low free thyroxine)[11]
- age- & sex-appropriate screening for cancer
Diagnostic procedures
- renal biopsy
- relatively safe
- indications
- abnormal serologic studies
- azotemia
- distinguish from nephritic syndrome
- contraindications:
- small kidneys: suggests scarring & fibrosis
Radiology
- renal ultrasound
- size of kidneys
- chronicity of disease
- evaluates obstruction
- renal vein doppler for renal vein thrombosis
- reflux nephropathy
- polycystic kidney disease
- often required for biopsy
- if kidneys are markedly diseased or scarred & small, aggressive workup should not be pursued[6]
- CT angiography if suspected renal vein thrombosis[14]
Complications
- deep vein thrombosis, pulmonary embolism, especially associated with membranous glomerulonephritis
- renal vein thrombosis is common (flank pain, worsening renal function)[14]
- excessive urine thyroxine causing hypothyroidism in patients on thyroxine-replacement therapy[8]
- hyperlipidemia
Management
- general measures
- ACE inhibitors or ARBs reduce proteinuria
- edema
- despite edema, patients are at risk for intravascular volume depletion
- loop diuretic (furosemide)
- +/- metolazone to mobilize edema
- combined with albumin infusion or addition of spironolactone for severe albuminuria[6]
- salt restriction 2-3 g sodium/day
- HMG CoA reductase inhibitor to reduce cholesterol
- heparin & warfarin to prevent emboli
- dietary protein titered to urinary losses
- immunosuppressive therapy
- in adults, obtain renal biopsy prior to initiating immunosuppressive therapy[6]
- glucocorticoids
- idiopathic nephrotic synrome frequently responds to glucocorticoids
- minimal change disease is the most responsive[6]
- prednisolone 1 mg/kg QD for 8 weeks
- cyclophosphamide (Cytoxan) 1-2 mg/kg QD for 8 weeks
- azathiaprine (Imuran)
- cyclosporine (Sandimmune)
- chlorambucil (Leukeran)
- pentoxyfylline (Trental)
- decreases hyperfiltration
- may be useful in diabetics
- adenosine receptor antagonist
- gel-foam ablation
- if proteinuria is so severe as to impair viabilility, the kidney may be infarcted with gel-foam by radiologic procedure
- hemodialysis:
- GFR < 30 mL/min is not an indication[6]
- evidence of uremic encephalopathy
- renal transplantation
- treat complications
- statin for hyperlipidemia
- anticoagulation for venous thromboembolism due to urinary loss of antithrombin
- low salt diet & loop diuretics for edema[6]
More general terms
More specific terms
- familial nephrotic syndrome
- isolated diffuse mesangial sclerosis (IDMS)
- steroid-resistance nephrotic syndrome
Additional terms
References
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 829-39.
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 270-71
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 520-522
- ↑ Orth SR, Ritz E The nephrotic syndrome. NEJM 338:1202-10, 1998 PMID: https://www.ncbi.nlm.nih.gov/pubmed/9554862
- ↑ Navarro JE et al Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration. Am J Kidney Disease 33:458 1999 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10070909
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2021.
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022 - ↑ 7.0 7.1 7.2 Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004
Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022 - ↑ 8.0 8.1 Rabin AS, Hamnvik OP, Robinson ES, Miller AL, Loscalzo J. CLINICAL PROBLEM-SOLVING. Springing a Leak. N Engl J Med 2015; 373:1362-1367. October 1, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26422727 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcps1401950
- ↑ Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012 Sep;82(6):635-42. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22718186
- ↑ Mirrakhimov AE, Ali AM, Barbaryan A et al Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature. Int J Nephrol. 2014;2014:916760. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24829800 Free PMC Article
- ↑ 11.0 11.1 11.2 Morris CA, Patel MJ, Fenves AZ, Masia R. Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distension and Pain. N Engl J Med 2018; 378:2124-2132. May 31, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29847754 https://www.nejm.org/doi/full/10.1056/NEJMcpc1712228
- ↑ Kodner C. Diagnosis and Management of Nephrotic Syndrome in Adults. Am Fam Physician. 2016 Mar 15;93(6):479-85. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26977832 Free Article
- ↑ Gyamlani G, Molnar MZ, Lu JL et al Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant. 2017 Jan 1;32(1):157-164. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28391310 Free PMC Article
- ↑ 14.0 14.1 14.2 NEJM Knowledge+ Nephrology/Urology
- ↑ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Nephrotic Syndrome in Adults https://www.niddk.nih.gov/health-information/kidney-disease/nephrotic-syndrome-adults
Chilhood Nephrotic Syndrome https://www.niddk.nih.gov/health-information/kidney-disease/children/childhood-nephrotic-syndrome